OGOlga M. Gordeeva

Olga M. Gordeeva

*This is an algorithmically generated author record based on publicly available information.

Olga M. Gordeeva has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Current possibilities of monitoring tuberculosis infection among kidney transplant candidates and kidney transplant recipients

    by O. M. Gordeeva, A. U. Borisova, I. U. Petrakova, N. L. Karpina

    Aim of the study . To determine the possibilities of monitoring tuberculosis infection among kidney transplant candidates and kidney transplant recipients using modern radiological examination methods. Materials and methods . In the period from 2012 to 2025, 63 patients with stage 5 CKD were examined at the Central Research Institute of Tuberculosis for tuberculosis infection of varying degrees of activity. According to the activity of the tuberculosis process, the patients were divided into 2 groups: patients with active tuberculosis — 23 people (36.5%), patients with residual post-tuberculous changes — 40 people (63.5%). A retrospective analysis of the results of radiation examination methods before the diagnosis of tuberculosis and at the time of diagnosis was carried out to identify residual post-tuberculosis changes (RPTC). For patients with RPTC, an analysis of the radiation examination methods results was also carried out before the diagnosis of the process and then for a long time with regular monitoring by the CT of the chest once every 6 months under the supervision of specialists. Results and discussion . Among CKD 5 stage patients with active tuberculosis, patients with widespread and complicated clinical forms of tuberculosis prevailed 17/23 people (73.9%): polyorgan tuberculosis — 6/23 people (26.1%), infiltrative pulmonary tuberculosis in the decay phase or with signs of complications (with bronchial damage) — 6/23 people (26.1%), disseminated pulmonary tuberculosis 3/23 people (13%) and others, which indicated late detection of the disease. It was found that the majority of patients (16/23 people (69.6%) had signs of RPTC at the time of active tuberculosis process diagnosis. When assessing the volume of RPTC, it was determined that large changes — 10/16 people (62.5%) prevailed. When assessing the localization of the tuberculosis process reactivation, it was found that in most cases 13/16 people (81.3%) the zone of inflammation development corresponded to the location of the transferred tuberculosis process signs. In this case, patients with CKD stage 5 with RPTC (40 people) were observed by specialists of Central Research Institute of Tuberculosis for a long time (more than 1 year, on average 3.86 years) with the performance of CT chest 1 time in 6 months, having received a course of chemoprophylaxis in a timely manner. 39/40 people (97.5%) did not have signs of tuberculosis reactivation, even after kidney transplantation or other events that aggravate the immunodeficiency state. Conclusion . In most patients with CKD stage five (69.6% of observations), the RPTC presence preceded the development of active tuberculosis, and in most cases (73.9%) of widespread and/or complicated tuberculosis processes. In this case, the zone of reactivation of the tuberculosis process in the observed patients mainly coincided with the localization of RPTC (81.3%). While observation of CKD stage 5 patients with RPTC using CT of the chest as a radiological examination made it possible in 97.5% of observations to promptly prescribe additional examination and carry out prevention of tuberculosis reactivation in patients with CKD stage 5.

  • Open Access

    Diagnostic labyrinth: case of late verification of polyorganic tuberculosis on the background of autoimmune hemolytic anemia

    by N. L. Karpina, A. D. Egorova, A. Yu. Borisova, O. M. Gordeeva

    The article presents a complex clinical case of late diagnosis of multiple organ tuberculosis in a 59-year-old female patient with autoimmune hemolytic anemia (AIHA). It delineates a ten-month diagnostic investigation during which the initial symptoms were interpreted by the medical professionals as manifestations of underlying hematological disease, its associated complications, or inefficacy of the antibiotic therapy. The authors highlight low informative value of the immunological tests (ATP test) when utilized in the context of immunosuppression caused by both AIHA and systemic glucocorticoid therapy. An analysis was conducted to identify diagnostic errors and factors contributing to delayed diagnosis. The conclusion drawn from this analysis indicates the need for high phthisiatric vigilance in patients with immunosuppressive conditions and importance of active use of invasive methods of diagnosis verification.

  • Tuberculosis is not an obstacle to kidney transplantation

    by O. M. Gordeeva, A. M. Tikhonov, N. L. Karpina

    Background . Monitoring patients with chronic kidney disease during preparation for kidney transplantation, in the immediate postoperative period and then over the years is a unique opportunity to verify the effectiveness of anti-tuberculosis therapy. The aim . To analyse the results of long-term observation of patients with chronic kidney disease stage 5 (CKD stage 5), who received a course of anti-tuberculosis therapy before kidney transplantation. Materials and methods . The analysis of the results of long-term observation of 7 patients with CKD stage 5 who had tuberculosis (TB) while receiving renal replacement therapy (RRT) using the method of programmed hemodialysis and continued observation by a phthisiatrician at the stages of preparation for kidney transplantation and for a year after, was carried out. Results . At the time of tuberculosis diagnosis, the observed multicomorbid patients had been on programmed hemodialysis for an average of 2.9 years. Anti-tuberculosis therapy was administered according to individualized regimens. The average waiting period for kidney transplantation for these patients was 3.6 years. Kidney transplantation was performed successfully in all 7 observed patients, after that all patients received three-component immunosuppressive therapy (tacrolimus, mycophenolate mofetil, methylprednisolone). Control examination to exclude reactivation of tuberculosis was carried out once every 6 months on a planned basis or upon complaints. The average follow-up period for recipients was 3.9 years. Reactivation of tuberculosis after kidney transplantation was recorded in only one patient. Thus, in 6/7 (85.7 %) patients with CKD with tuberculosis infection, kidney transplantation and administration of immunosuppressive therapy were performed without reactivation of tuberculosis. Conclusions . The long-term absence of tuberculosis reactivation in the majority of patients (85.7 %) against the background of not only renal failure, but also immunosuppressive therapy after kidney transplantation was achieved through an individual approach to the treatment and management of each patient with CKD and interdisciplinary interaction of doctors.

  • Open Access

    Impact of Diabetes Mellitus and Viral Hepatitis on the Toxicity Profile of Pre-Extensively Drug-Resistant Tuberculosis Chemotherapy: Focus on Neurotoxicity and Ototoxicity

    by Alexey M. Tikhonov, Olga M. Gordeeva, Sergei A. Pavlov

    Objective: To analyse the impact of comorbid conditions (diabetes mellitus, viral hepatitis) on the frequency and spectrum of adverse drug reactions (ADRs) during the treatment of pre-extensively drug-resistant (Pre-XDR) pulmonary tuberculosis, with a specific focus on mitochondrial toxicity. Materials and Methods: A retrospective cohort study of 247 HIV-negative patients with Pre-XDR tuberculosis was conducted. Patients received chemotherapy regimens containing linezolid, fluoroquinolones, and injectable agents (consistent with guidelines prior to the 2021 WHO update). Toxicity was graded according to CTCAE standards. The correlation between comorbidities and the incidence of neurotoxic and hepatotoxic ADRs was assessed using multivariate regression analysis. Results: High comorbidity burden was identified as an independent predictor of treatment failure (OR=3.45; p=0.007). The cohort was characterized by a high prevalence of viral hepatitis B/C (up to 12.2%) and diabetes mellitus (up to 10.2%). The most frequent ADRs were eosinophilia (33.6%), ototoxicity (26.3%), and polyneuropathy (up to 15.2% in previously treated patients). Surprisingly, age < 40 years was associated with poor outcomes (OR=4.15; p=0.013), likely driven by lower adherence. The development of severe ADRs significantly increased the risk of treatment failure (OR=4.17; p=0.037). Conclusion: The combination of Pre-XDR tuberculosis with metabolic comorbidities creates a synergistic “mitochondrial hit” effect. This manifests as increased neurotoxicity (attributable to linezolid) and ototoxicity. Even in the era of all-oral regimens, the intersection of diabetes and linezolid-based therapy requires enhanced neuroprotective monitoring.

  • Open Access

    Difficult case of differential diagnosis of partial lung atelectasis. Case report

    by O M Gordeeva, A D Egorova, Y O Chesalina, E M Gretcov, L A Semenova, N L Karpina, I V Sivokozov

    In December 2018 the patient over 60 years old sought medical help with complaints of persistent cough. Based on computed tomography data there were identified the sings (symptoms) of right lung lower lobe atelectasis. To run this patient diagnostics there were performed 6 bronchoscopies narrowed down by bronchi checks up only and described the right lung central cancer picture. At the same time the biopsy taken during one of the bronchoscopies appeared non informative. Fine needle biopsy of mediastinal lymph nodes and bronchial wall was performed twice: at Tomsk Cancer Research Institute (it was suspected B-cell lymphoma based on biopsy examination) and at The Loginov Moscow Clinical Scientific Center (signs of inflammation based on biopsy examination). The video-assisted thoracoscopy with lymph node dissection of the right lung root was performed in January 2020. As a surgical material analysis result reactive adenopathy was determined. Therefore, during more than 1 year of diagnostic research the genesis of right lung lower lobe atelectasis was not established. The patient was directed to Central Tuberculosis Research Institute for diagnosis verification. Based on clinical and radiological picture Central Tuberculosis Research Institute colleagues suspected a foreign body in the intermediate bronchus. During an endoscopic examination it was revealed stenosis, biopsies were performed, but the foreign body could not be identified. In the pathomorphological laboratory of Central Tuberculosis Research Institute there were conducted histological examination of the material after endobronchial cryobiopsy and rigid needle biopsy. Both gave an unexpected result: invasive mycosis of the bronchial wall. As a conclusion the decision was taken to apply antimycotic therapy on an outpatient basis. As a result, clear clinical and radiological positive dynamics was obtained. In these favorable conditions for endoscopic examination, it was performed vitally essential cryoextraction of foreign body. The foreign body turned out to be a fragment of a spongy bone of a centimeter size. These actions have let to unlock the right lung lower lobe.


  • Open Access

    Problems of anti-tuberculosis therapy in patients on hemodialysis

    by O. M. Gordeeva, A. M. Tikhonov, S. N. Andreevskaya, E. E. Larionova, N. L. Karpina

    Цель исследования: определить возможность назначения и безопасность применения различных противотуберкулезных препаратов и их комбинаций в рамках терапевтического или профилактического курса противотуберкулезной терапии (ПТТ) у больных в терминальной стадии хронической болезни почек (ТХБП), получающих заместительную терапию гемодиализом в условиях высокой распространенности штаммов микобактерий туберкулеза (МБТ) с лекарственной устойчивостью. Материалы и методы. Под наблюдением в ФГБНУ «ЦНИИТ» находилось 42 больных, получающих заместительную терапию гемодиализом: с активным туберкулезом – 31 (73,8%) чел., с остаточными посттуберкулезными изменениями органов дыхания – 11 (26,2%) чел. За период наблюдения проведена оценка характера и степени тяжести нежелательных реакций на противотуберкулезные препараты. Результаты. У больных ТХБП с туберкулезом органов дыхания преобладают лекарственно-устойчивые штаммы возбудителя – 68,2%. Среди нежелательных явлений при приеме противотуберкулезных препаратов встречались: нарастание явлений уремии ‒ в 20,5% наблюдений, сердечно-сосудистые осложнения – в 17,9% и нейротоксические реакции – в 15,4%. Нарастание уремии при приеме противотуберкулезных препаратов у наблюдаемых больных встречалось достоверно чаще, чем гепатотоксические реакции (p = 0,02). При лечении туберкулеза у больных ТХБП из-за нежелательных явлений требовалась отмена изониазида в 12,8% наблюдений и пиразинамида в 12,8% наблюдений, другие препараты реже. Индивидуализированный подбор ПТТ с учетом данных теста лекарственной чувствительности МБТ, противопоказаний, сопутствующих заболеваний позволил подобрать адекватную ПТТ больным ТХБП с туберкулезной инфекцией в 92,9% на срок более 6 мес.

  • Risk factors identification of respiratory tuberculosis progression in patients with end-stage renal disease

    by Federal State Budgetary Scientific Institution, O.M. Gordeeva, Central TB Research Institute", ( Fsbsi, N.L. Karpina, Federal State Budgetary Scientific Institution "Central TB Research Institute" (FSBSI "Central TB Research Institute")

  • Adverse effects analysis results during anti-TB treatment among hemodialysis patients

    by Olga Gordeeva, Natalya Karpina, Sofya Andreevskaya, Elena Larionova

    Introduction: The presence of active tuberculosis (TB), post TB changes or latent TB infection among hemodialysis (HD) patients require anti-TB treatment. It added complexity for most of doctor. Aim. To provide an analysis for adverse effects (AE) among HD patients during anti-TB treatment. Materials and methods: We studied 42 HD patients (f. - 54.8%, m. 45.2%, age - 39.45 years): with active TB - 73.8%, with residual post-TB changes - 26.2%. Results: Active TB identified in 77.4% cases: the sensitivity preserved in 31.8%, H- resist. - 18.2%, MDR - 45.5%, XDR - 4.5%. Due to contraindications taken place standard regimens were not applicable. There were introduced 24 schemes of anti-TB therapy. Anti-TB therapy was selected in 92.9%. During anti-TB treatment an increase of uremia - 20.5%, cardiovascular complications - 17.9%, neurotoxic reactions - 15.4%, toxic-allergic reactions - 10.3%, articular syndrome - 5.1%, cardiac conduction disorders - 5.1%, indomitable vomiting and hematotoxic reactions - 2.6%. Most often canceled anti-TB drugs: H - 12.8%, Z - 12.8%, R - 10.3%, Et - 10.3%, PAS - 5.1%, one patient per each drug reported improvement after withdrawal Lfx, Am, Cs, Pt. Conclusion: Patients with drug-resistant TB predominate - 68.2%. During HD patients TB treatment standard regimens are not applicable, the treatment duration exceeds 6 months. In 92.9% of HD patients, it is possible to select anti-TB therapy. Among the AE of anti-TB drugs, there is more often an increase of uremia - 20.5%, cardiovascular complications - 17.9%. The drugs requiring withdrawal were often H - 12.8%, Z - 12.8%.

  • The role of bronchoscopy in the differential diagnosis of pulmonary lesions in end-stage renal disease patients

    by Olga Gordeeva, Natalia Karpina, Ilya Sivokozov, Yulia Turovtceva, Irina Shabalina, Dmitry Dedushkin

    Introduction: Patients with end-stage renal disease (ESRD) patients are at risk for invasive diagnostic procedures. The question about the possibility of bronchoscopy in these patients with suspected pulmonary TB or intrathoracic lymph nodes (ILN) is problem associated with a high risk of complications. Aim of study: To estimate the relevance of white light bronchoscopy (WLBr) with biopsies for examination of tracheobronchial tree and identifying endobronchial lesions in ESRD pts with newly detected changes of lungs and/or ILN. Materials and Methods: 36 ESRD patients with changes in the lungs/ILN on chest CT scans underwent bronchoscopic biopsies: BAL/BW- 22 cases, BAL/brush biopsy-11 cases, BAL/EBB-2 cases, EUSb-FNA of INL-1. Results: 36 ESRD pts performed a WLBr with biopsies under local anesthesia 31(86.1%) cases, under intravenous sedation (13.9%) - 5 pts. Еndobronchial pathology was not detected in 5/36 (13.9%) pts. The changes of bronchial mucosa specific to DS of Endobronchial Tuberculosis (EBTB) found in 11/36 (30.6%) pts. EBTB was identified in 5 cases, including actively caseation type - 3 pts, ulcerative type - in 2 pts; fibrostenotic type - 6 pts. Nonspecific purulent bronchitis found in 6 (16.7%) pts. Atrophic bronchitis was detected in 7 (19.4%) cases. All patients showed a reversible hypertension and mild post biopsy bleeding. No complications occurred. DS was confirmed in 33/36 (91.7%) cases by bronchoscopically and 3 pts. (8.3%) underwent thoracic surgery to verify the DS of TB. Conclusions: Results support the relevant role of WLBr for DS of EBTB (30,6%) and biopsies for DS pulmonary TB (91,7%) in ESRD patients.

  • Quantiferon test in the complex diagnosis of tuberculosis in patients with end-stage kidney disease

    by Olga Gordeeva, Vladislav Hergert, Irina Lyadova, Natalya Karpina

    Introduction: In patients with end-stage kidney disease (ESKD), the diagnosis of tuberculosis is extremely difficult due to the lack of a classical clinical and radiological picture of the tuberculosis process, oligobacillarity and anergy of tuberculin skin tests (TST). Now, studies of the efficiency of the quantiferon test among immunocompromised populations are being conducted worldwide, but there is very little information about efficiency of this test in patients with ESKD. Aim of study. To study the value of the quantiferon test in the complex diagnosis of respiratory tuberculosis in patients with ESKD. Materials and Methods: Immunological studies (quantiferon test and tuberculin skin test) were performed in 23 pts. with ESKD who applied to the Central TB Research Institute to clarify the diagnosis since 2010 until 2019. Changes in the lungs and/or fever in these pts. were revealed for the first time. Results: According to the results of the survey in 10 out of 23 ESKD pts. (43.5%) the diagnosis of active respiratory TB was verified. Other active respiratory diseases were diagnosed in 13/23 pts. (56.5%). Skin test showed a lower sensitivity (60%) compared to the QuantiFERON®-TB Gold Plus test (70%), while both tests were highly specific (100%) in the detection of TB in ESKD pts. For all indicators, statistical significance was determined (p <0.05). The agreement coefficient (Kappa) of the QuantiFERON®-TB Gold Plus test results with the skin test results was 0.671. Conclusions. Given the high specificity (100%) and sensitivity (70%), it is possible to consider the use of the QuantiFERON®-TB Gold Plus test as an additional method for the diagnosis of tuberculosis in ESKD pts